By Media Staff | Friday, August 30, 2013
Memorial Sloan Kettering’s Patient Recreation Pavilion offers a healing environment where patients and their loved ones come to discover or rediscover the things that bring them enjoyment.
By Memorial Sloan Kettering | Wednesday, August 28, 2013
Dr. Ganly explains that experts in all disciplines – including medical oncology, radiation oncology, and surgery – work together as a team to deliver treatments offering the best results possible for patients.
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor | Monday, August 26, 2013
A recent study found that the cell lines most commonly used for research on ovarian cancer are not the most suitable.
By Christina Pernambuco-Holsten, MA | Friday, August 23, 2013
Our summer fellowship program helps medical students learn to become physician-scientists. Read about one of our trainees who investigated an imaging tool for use in patients with a rare uterine cancer.
In the Clinic
By Maureen Salamon, BA, Freelance Writer | Thursday, August 22, 2013
An international study led by Memorial Sloan Kettering found that pazopanib (Votrient®) controls cancer as effectively as sunitinib (Sutent®) while improving patients’ quality of life.
By Christina Pernambuco-Holsten, MA | Monday, August 19, 2013
Dermatologist Mario Lacouture describes common skin reactions that can develop as a result of cancer treatment and offers tips for lessening their impact.
By Andrea Peirce, BA, Writer/Editor | Friday, August 16, 2013
Memorial Sloan Kettering uses a multidisciplinary approach to provide leading-edge care to women with cervical cancer.
By James Eastham, MD and Vincent Laudone, MD
Wednesday, August 14, 2013
Active surveillance is the most appropriate management strategy for many men with prostate cancer, but often this option is never mentioned.
In the Lab
By Esther Napolitano, BS, Science Writer/Editor | Friday, August 9, 2013
A Memorial Sloan Kettering study shows that an abnormal cell pattern found in the tumor tissue of some lung cancer patients may help to predict which tumors are more likely to recur after surgery.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Wednesday, August 7, 2013
Information about the microbiome, the genes of all the microorganisms that naturally inhabit the human body, is leading to new approaches for treating infections in cancer patients.
By Julie Grisham, MS, Science Writer/Editor | Monday, August 5, 2013
Jorge Reis-Filho studies the genetic alterations that drive the malignant behavior of cells in rare types of breast cancer.
In the News
By Media Staff | Wednesday, July 31, 2013
Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton was interviewed on PBS NewsHour about a recent recommendation from a National Cancer Institute working group that proposed changing the definition of cancer.
In the Clinic
By Jim Stallard, MA, Writer/Editor | Tuesday, July 30, 2013
A new online decision tool can help current or former smokers determine whether they would benefit from lung cancer screening.
By Christina Pernambuco-Holsten, MA | Monday, July 29, 2013
Bridges, Memorial Sloan Kettering’s newsletter written by and for cancer survivors, celebrates its fifth year of publication this summer.
By Paul Sabbatini, MD, Deputy Physician-in-Chief for Clinical Research | Friday, July 26, 2013
The clinical trial remains our best tool to identify new therapies, but as with all tools, innovation is required if trials are to remain relevant.